Supplementary Tables from Discovery of a Novel ATP-Competitive MEK Inhibitor DS03090629 that Overcomes Resistance Conferred by BRAF Overexpression in BRAF-Mutated Melanoma

Spremljeno u:

Bibliografski detalji
Glavni autor:	Kohei Takano (15093373) (author)
Daljnji autori:	Yoichi Munehira (15093376) (author), Mana Hatanaka (15093379) (author), Ryo Murakami (15093382) (author), Yoshihiro Shibata (15093385) (author), Takeshi Shida (15093388) (author), Kosuke Takeuchi (15093391) (author), Sho Takechi (15093394) (author), Toshiki Tabata (15093397) (author), Takashi Shimada (15093400) (author), Shuhei Kishikawa (15093403) (author), Yumi Matsui (15093406) (author), Osamu Ubukata (15093409) (author), Takahiko Seki (15093412) (author), Yasuyuki Kaneta (15093415) (author)
Izdano:	2025
Teme:	Cancer Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Biophysical Technologies X-ray crystallography Cell Signaling Protein serine-threonine kinases Drug Resistance Regulation of gene expression in drug resistance Drug Targets Protein kinase & phosphatase drug targets Preclinical Models In vitro models of cancer Xenograft models Skin Cancers Melanoma Small Molecule Agents Kinase inhibitors
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!

Slični predmeti